Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | KOD |
---|---|---|
09:32 ET | 5115 | 2.49 |
09:34 ET | 314 | 2.5 |
09:36 ET | 4380 | 2.48 |
09:38 ET | 2009 | 2.4692 |
09:39 ET | 1660 | 2.47 |
09:41 ET | 400 | 2.47 |
09:43 ET | 300 | 2.47 |
09:45 ET | 125 | 2.4609 |
09:50 ET | 1045 | 2.4549 |
09:52 ET | 1900 | 2.4445 |
09:54 ET | 300 | 2.43 |
09:56 ET | 1893 | 2.455 |
09:57 ET | 4007 | 2.455 |
10:03 ET | 100 | 2.445 |
10:06 ET | 300 | 2.445 |
10:08 ET | 100 | 2.445 |
10:10 ET | 100 | 2.43 |
10:12 ET | 400 | 2.43 |
10:14 ET | 400 | 2.445 |
10:15 ET | 493 | 2.44 |
10:17 ET | 1282 | 2.42 |
10:19 ET | 1802 | 2.4 |
10:21 ET | 4055 | 2.38 |
10:24 ET | 700 | 2.36 |
10:26 ET | 5815 | 2.418 |
10:30 ET | 3902 | 2.38 |
10:32 ET | 1672 | 2.399 |
10:33 ET | 596 | 2.4 |
10:35 ET | 2405 | 2.4 |
10:37 ET | 400 | 2.39 |
10:39 ET | 402 | 2.4 |
10:42 ET | 428 | 2.39 |
10:44 ET | 600 | 2.38 |
10:46 ET | 1104 | 2.38 |
10:48 ET | 3820 | 2.4 |
10:50 ET | 247 | 2.4 |
10:51 ET | 100 | 2.39 |
10:53 ET | 1103 | 2.4 |
10:55 ET | 200 | 2.39 |
10:57 ET | 1200 | 2.39 |
11:00 ET | 666 | 2.39 |
11:02 ET | 100 | 2.39 |
11:04 ET | 606 | 2.38 |
11:06 ET | 400 | 2.38 |
11:08 ET | 400 | 2.38 |
11:09 ET | 339 | 2.38 |
11:11 ET | 1379 | 2.37 |
11:13 ET | 200 | 2.37 |
11:18 ET | 400 | 2.37 |
11:20 ET | 10653 | 2.35 |
11:22 ET | 2454 | 2.36 |
11:26 ET | 100 | 2.35 |
11:27 ET | 200 | 2.36 |
11:29 ET | 200 | 2.35 |
11:31 ET | 304 | 2.355 |
11:33 ET | 6228 | 2.355 |
11:36 ET | 366 | 2.35 |
11:38 ET | 1200 | 2.335 |
11:40 ET | 891 | 2.335 |
11:42 ET | 352 | 2.33 |
11:44 ET | 118 | 2.33 |
11:45 ET | 9925 | 2.355 |
11:47 ET | 668 | 2.36 |
11:49 ET | 349 | 2.36 |
11:51 ET | 202 | 2.36 |
11:54 ET | 1241 | 2.36 |
11:56 ET | 888 | 2.35 |
11:58 ET | 400 | 2.36 |
12:00 ET | 447 | 2.35 |
12:02 ET | 646 | 2.34 |
12:03 ET | 300 | 2.345 |
12:05 ET | 346 | 2.34 |
12:07 ET | 700 | 2.34 |
12:09 ET | 239 | 2.345 |
12:12 ET | 1786 | 2.355 |
12:14 ET | 118 | 2.35 |
12:16 ET | 19397 | 2.355 |
12:18 ET | 21409 | 2.39 |
12:20 ET | 6459 | 2.387 |
12:21 ET | 1454 | 2.38 |
12:23 ET | 2700 | 2.375 |
12:25 ET | 463 | 2.375 |
12:27 ET | 100 | 2.37 |
12:30 ET | 3939 | 2.374 |
12:32 ET | 1620 | 2.365 |
12:34 ET | 100 | 2.36 |
12:36 ET | 528 | 2.36 |
12:38 ET | 1796 | 2.365 |
12:39 ET | 951 | 2.365 |
12:41 ET | 1839 | 2.375 |
12:45 ET | 929 | 2.37 |
12:48 ET | 800 | 2.36 |
12:50 ET | 327 | 2.365 |
12:52 ET | 400 | 2.365 |
12:54 ET | 170 | 2.365 |
12:56 ET | 426 | 2.36 |
12:57 ET | 200 | 2.365 |
12:59 ET | 319 | 2.365 |
01:01 ET | 705 | 2.35 |
01:06 ET | 341 | 2.355 |
01:08 ET | 200 | 2.35 |
01:10 ET | 229 | 2.35 |
01:12 ET | 495 | 2.34 |
01:14 ET | 600 | 2.33 |
01:15 ET | 2423 | 2.32 |
01:17 ET | 506 | 2.31 |
01:19 ET | 929 | 2.31 |
01:21 ET | 1554 | 2.2999 |
01:24 ET | 100 | 2.295 |
01:26 ET | 1848 | 2.3099 |
01:28 ET | 900 | 2.3 |
01:30 ET | 1052 | 2.29 |
01:32 ET | 100 | 2.295 |
01:33 ET | 776 | 2.29 |
01:35 ET | 100 | 2.29 |
01:37 ET | 740 | 2.29 |
01:39 ET | 1902 | 2.295 |
01:42 ET | 1000 | 2.3 |
01:44 ET | 1200 | 2.315 |
01:46 ET | 1094 | 2.31 |
01:50 ET | 736 | 2.305 |
01:51 ET | 100 | 2.305 |
01:53 ET | 210 | 2.3 |
01:55 ET | 570 | 2.305 |
01:57 ET | 300 | 2.3 |
02:00 ET | 638 | 2.3053 |
02:02 ET | 1942 | 2.305 |
02:04 ET | 816 | 2.3 |
02:06 ET | 1351 | 2.295 |
02:08 ET | 779 | 2.29 |
02:09 ET | 1858 | 2.305 |
02:11 ET | 331 | 2.3 |
02:13 ET | 540 | 2.31 |
02:15 ET | 570 | 2.3 |
02:18 ET | 657 | 2.31 |
02:20 ET | 259 | 2.315 |
02:22 ET | 600 | 2.32 |
02:24 ET | 438 | 2.31 |
02:26 ET | 958 | 2.32 |
02:27 ET | 100 | 2.32 |
02:29 ET | 772 | 2.325 |
02:31 ET | 315 | 2.32 |
02:33 ET | 100 | 2.32 |
02:36 ET | 738 | 2.325 |
02:40 ET | 621 | 2.325 |
02:42 ET | 900 | 2.33 |
02:44 ET | 167 | 2.335 |
02:45 ET | 1072 | 2.33 |
02:49 ET | 1703 | 2.345 |
02:54 ET | 1322 | 2.34 |
02:56 ET | 279 | 2.335 |
02:58 ET | 1311 | 2.33 |
03:00 ET | 489 | 2.33 |
03:02 ET | 523 | 2.335 |
03:03 ET | 292 | 2.335 |
03:05 ET | 1206 | 2.325 |
03:07 ET | 400 | 2.325 |
03:09 ET | 1893 | 2.325 |
03:12 ET | 800 | 2.315 |
03:14 ET | 500 | 2.31 |
03:16 ET | 634 | 2.315 |
03:18 ET | 500 | 2.31 |
03:20 ET | 1724 | 2.305 |
03:21 ET | 600 | 2.305 |
03:23 ET | 3911 | 2.315 |
03:25 ET | 1267 | 2.315 |
03:27 ET | 400 | 2.315 |
03:30 ET | 2092 | 2.315 |
03:32 ET | 500 | 2.315 |
03:34 ET | 5601 | 2.315 |
03:36 ET | 2268 | 2.315 |
03:38 ET | 3826 | 2.305 |
03:39 ET | 4200 | 2.3 |
03:41 ET | 920 | 2.3 |
03:43 ET | 4235 | 2.305 |
03:45 ET | 1224 | 2.305 |
03:48 ET | 1300 | 2.3 |
03:50 ET | 19051 | 2.305 |
03:52 ET | 1888 | 2.305 |
03:54 ET | 2789 | 2.305 |
03:56 ET | 13487 | 2.295 |
03:57 ET | 3958 | 2.29 |
03:59 ET | 13385 | 2.29 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Kodiak Sciences Inc | 132.9M | -0.5x | --- |
Elevation Oncology Inc | 131.7M | -2.3x | --- |
Nuvectis Pharma Inc | 130.3M | -4.6x | --- |
Atossa Therapeutics Inc | 129.5M | -4.5x | --- |
Cytodyn Inc | 136.6M | -2.6x | --- |
Acumen Pharmaceuticals Inc | 128.6M | -2.0x | --- |
Kodiak Sciences Inc. is a biopharmaceutical company. The Company has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) Platform, for retinal medicines. Its ABC Platform uses molecular engineering to merge the fields of protein-based and chemistry-based therapies. Its lead investigational medicine, tarcocimab, is a novel anti-vascular endothelial growth factor (anti-VEGF) antibody biopolymer conjugate under development for the treatment of high prevalence retinal vascular diseases, including diabetic retinopathy, the cause of blindness in working-age patients in the developed world, and wet age-related macular degeneration, the cause of blindness in elderly patients. Its second investigational medicine, KSI-501, is a bispecific antibody biopolymer conjugate targeting the pro-inflammatory cytokine interleukin-6 (IL-6) and VEGF. It is also developing a third investigational medicine, KSI-101, an unconjugated bispecific protein targeting IL-6 and VEGF.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $132.9M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 52.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.38 |
EPS | $-4.44 |
Book Value | $5.06 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.